Stockreport

Evaxion Announces Business Update and Full Year 2023 Financial Results

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF Precision vaccine project initiated with the ambition to obtain Preclinical Proof-of-Concept by H2 2024. The novel concept entails AI-identification of a new class of ca [Read more]